Skip to main content
Log in

Effects of garlic coated tablets in peripheral arterial occlusive disease

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

For the first time, a weak clinical efficacy of a 12-week therapy with garlic powder (daily dose, 800 mg) is demonstrated in patients with peripheral arterial occlusive disease stage II. The increase in walking distance in the verum group by 46 m (from 161.0 ± 65.1 to 207.1 ± 85.0 m) was significantly higher (P<0.05) than in the placebo group (by 31 m, from 172.0 ± 60.9 to 203.1 ± 72.8). Both groups received physical therapy twice a week. The diastolic blood pressure, spontaneous thrombocyte aggregation, plasma viscosity, and cholesterol concentration also decreased significantly. Body weight was maintained. It is quite interesting that the garlic-specific increase in walking distance did not appear to occur until the 5th week of treatment, connected with a simultaneous decrease in spontaneous thrombocyte aggregation. Therefore, garlic may be an appropriate agent especially for the long-term treatment of an incipient intermittent claudication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

PAOD:

peripheral arterial occlusive disease

References

  1. Alström T, Grdsbeck R, Hjelm M, Skandsen S (1975) Recommendations concerning the collection of reference values in clinical chemistry and activity report. Scand J Clin Lab Invest 35:1–43

    Google Scholar 

  2. Bauer U (1984) 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforschung 34:110–114

    Google Scholar 

  3. Bents H, Buchkremer G (1987) Raucherentwöhnung. Psychologische und pharmakologische Methoden. Dtsch Med Wochenschr 112:559–564

    Google Scholar 

  4. Bollinger A, Frei C (1977) Double-blind study of pentoxifylline against placebo in patients with intermittent claudication. Pharmatherapeutica 1:557

    Google Scholar 

  5. Bordia AK, Joshi HK, Sanadhya YK, Bhu N (1977) Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 28:155–159

    Google Scholar 

  6. Boullin DJ (1981) Garlic as a platelet inhibitor. Lancet 4:776–777

    Google Scholar 

  7. Breddin K, Grun H, Krzywanek HJ, Schremmer MM (1975) On the measurement of spontaneous thrombocyte aggregation. The platelet aggregation. II. Methods and first clinical results. Thromb Haemost 48:261–272

    Google Scholar 

  8. Chutani SK, Bordia A (1981) The effect of fried versus raw garlic on fibrinolytic activity in man. Atherosclerosis 38:417–421

    Google Scholar 

  9. Foushee DB, Ruffin J, Banerjee U (1982) Garlic as a natural agent for the treatment of hypertension: a preliminary report. Cytobios 34:145–152

    Google Scholar 

  10. Heidrich H, Boccalon HJL (1986) Prinzipien kontrollierter klinischer Therapiestudien bei peripherer arterieller Verschlußkrankheit. Angio Archiv 13:17–21

    Google Scholar 

  11. Jung F, Kiesewetter H, Roggenkamp HG, Nüttgens HP, Ringelstein EB, Gerhards M, Kotitschke G, Wenzel E, Zeller H (1986) Bestimmung der Referenzbereiche rheologischer Parameter: Studie an 653 zufällig ausgewählten Probanden im Kreis Aachen. Klin Wochenschr 64:375–381

    Google Scholar 

  12. Jung F, Wolf S, Kiesewetter H, Mrowietz C, Pindur G, Heiden M, Myashita C, Wenzel E, Reim M (1989) Wirkung von Knoblauch auf die Fließfähigkeit des Blutes. Ergebnisse placebo-kontrollierter Pilotstudien an gesunden Probanden. Natur- and Ganzheitsmedizin 7:216–221

    Google Scholar 

  13. Krause D, Dittmar K (1976) Kombination krankengymnastischer Übungen mit Bencyclan bei Claudicatio intermittens. Münchner Med Wochenschr 118:1281–1284

    Google Scholar 

  14. Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühil U, Rudosky G, Trübestein R, Trübestein G (1984) Naftidrofuryl bei arterieller Verschlußkrankheit. Kontrollierte multizentrische Doppelblindstudie mit oraler Applikation. Dtsch Med Wochenschr 109:745

    Google Scholar 

  15. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE (1982) Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 104:66

    Google Scholar 

  16. Sainani GS, Desai DB, Gorhe NH, Natu SM, Pise DV, Sainani PG (1979) Effect of dietary garlic and onion on serum lipid profile in Jain community. Indian J Med Res 69:776–780

    Google Scholar 

  17. Schraeder R (1984) Wirksamkeit von Padma 28 auf die Claudicatio intermittens bei chronisch peripherer arterieller Verschlußkrankheit. University of Berne, thesis

  18. Trampisch HJ (1986) Statistische Basis für kontrollierte klinische Studien bei peripherer-arterieller Verschlußkrank-heit. Angio Archiv 13:9–13

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. N. Zöllner on the occasion of his 70th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiesewetter, H., Jung, F., Jung, E. et al. Effects of garlic coated tablets in peripheral arterial occlusive disease. Clin Investig 71, 383–386 (1993). https://doi.org/10.1007/BF00186628

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00186628

Key words

Navigation